NCT04872413View on ClinicalTrials.gov

Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

February 21, 2025

Study Completion Date

February 21, 2025

Conditions
Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood, saliva or tissue sample collection

OTHER

Follow-Up

Undergo follow-up

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT04872413 - Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial | Biotech Hunter | Biotech Hunter